Skip to content

Effects of acute exercise on acetylcarnitine concentration in endurance trained- and untrained subjects

Effects of acute exercise on acetylcarnitine concentration in endurance trained- and untrained subjects - Acetylcarnitine in exercise

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON37450
Enrollment
13
Registered
2012-01-18
Start date
2012-04-27
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inactivity Insulin resistance

Interventions

N.A.

Sponsors

Academisch Ziekenhuis Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Age 18-40 years - Normal weight (BMI 18-25 kg/m2) - Healthy - Stable dietary habits - No use of medication - VO2-max for trained subjects above 50 mL/min/kg - VO2-max for untrained subjects below 40 mL/min/kg

Exclusion criteria

Exclusion criteria: - Any medical condition requiring treatment and/or medication use OR diminishing exercise tolerance - Alcohol consumption of more than 20 g per day (± 2 units) - Unstable body weight (weight gain or loss > 3 kg in the past three months) - Participation in another biomedical study within 1 month prior to the screening visit - Contraindications for MRI scan * Central nervous system aneurysm clips * Implanted neural stimulator * Implanted cardiac pacemaker of defibrillator * Cochlear implant * Iron- containing corpora aliena in the eye or brain * Hearing aids and artificial (heart) valves which is contraindicated for MRS

Design outcomes

Primary

MeasureTime frame
Exercise-induced changes in acetylcarnitine concentrations and dynamics of acetylcarnitine restoration after exercise

Secondary

MeasureTime frame
* Substrate oxidation * Blood plasma levels of FFA, triglycerides, glucose and catecholamines

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)